ACTIVE

Ap. Pharmamax

Export PDF

Financial year 2024 · closed on 31/12/2024

Net result

290,2 k €

-10.2% YoY

Gross margin

353,4 k €

-4.1% YoY

Equity

350 k €

+0.1% YoY

Workforce

0,8 ETP

0.0% YoY

What does Ap. Pharmamax do?

Ap. Pharmamax is a Private company with limited liability incorporated in 1988. Its registered office is in Boom. It employs on average 0,8 ETP workers (FTE).

Legal situation

● Normal situation

BCE/KBO no. / VAT

BE 0434.458.941

Incorporation

04/06/1988

Legal form

Private company with limited liability

Registered office

Peter Benoitstraat 46
2850 Boom · FlandreSee on map

Contributed capital

25 000,00 €

Latest accounts

31/12/2024

Average workforce

0,8 ETP

Joint committees (1)

Signals

ProfitableSolid equityLow riskGood liquidityPositive cashflowPositive EBITDAHealthy social debts

View the BCE/KBO Public Search record →

Health score

Available with a Rovalta subscriptionTry for 7 days

Recommended credit limit

✦ Verdict · Analyst summary

Financials

Trend over 14 financial years

	2024		2023		2022		2021		2014		2013		2012		2011		2010		2010		2009		2008		2007		2006
Income statement
Gross margin	353,4 k €	-4.1%	368,4 k €	+2.0%	361,2 k €	+12.9%	320 k €	+117%	147,3 k €	+4.6%	140,9 k €	-22.9%	182,7 k €	+22.0%	149,8 k €	+14.7%	130,6 k €	+36.5%	95,7 k €	+43.8%	66,5 k €	-21.7%	84,9 k €	-48.0%	163,4 k €	+35.4%	120,6 k €
EBITDA	323,9 k €	-6.5%	346,5 k €	+5.5%	328,3 k €	+14.5%	286,8 k €	+17290%	1,6 k €	+101%	-132,3 k €	-869%	17,2 k €	+1586%	1 k €	-98.6%	72,2 k €	+56.0%	46,3 k €	+180%	16,5 k €	-46.9%	31,1 k €	-41.6%	53,3 k €	+253%	15,1 k €
Operating result	312 k €	-6.1%	332,2 k €	+3.8%	320,1 k €	+17.5%	272,4 k €	+2046%	-14 k €	+90.5%	-147,4 k €	-935%	-14,2 k €	+41.0%	-24,1 k €	-140%	60,1 k €	+158%	23,3 k €	+706%	2,9 k €	-89.9%	28,6 k €	-25.8%	38,5 k €	+6027%	629 €
Net result	290,2 k €	-10.2%	323 k €	+45.3%	222,4 k €	+18.1%	188,3 k €	+775%	-27,9 k €	+82.2%	-156,5 k €	-179%	-56,2 k €	+12.6%	-64,3 k €	-310%	30,5 k €	+664%	-5,4 k €	+31.9%	-7,9 k €	-218%	6,7 k €	-57.7%	15,9 k €	+172%	-22,2 k €
Balance sheet
Equity	350 k €	+0.1%	349,8 k €	+7.0%	326,8 k €	+213%	104,4 k €	+180%	-131,2 k €	-27.0%	-103,3 k €	-294%	53,2 k €	-51.4%	109,4 k €	-37.0%	173,7 k €	+21.3%	143,1 k €	-3.6%	148,6 k €	-5.1%	156,5 k €	+4.5%	149,8 k €	-23.5%	195,9 k €
Total assets	1 M €	+18.6%	851,8 k €	+48.7%	572,9 k €	+25.8%	455,5 k €	+43.0%	318,5 k €	-22.6%	411,6 k €	-2.0%	420 k €	-21.7%	536,8 k €	-20.9%	678,7 k €	+11.3%	609,5 k €	+13.7%	536 k €	+156%	209,7 k €	-11.7%	237,5 k €	-3.6%	246,4 k €
Cash	355,5 k €	+3.5%	343,5 k €	+47.7%	232,5 k €	+117%	106,9 k €	+7170%	1,5 k €	-98.2%	81,9 k €	+43.4%	57,1 k €	-65.7%	166,4 k €	+114%	77,8 k €	-61.3%	200,9 k €	+1.0%	198,8 k €	+138%	83,6 k €	+40.0%	59,7 k €	+21.5%	49,1 k €
Debts	660,1 k €	+58.9%	415,4 k €	+68.8%	246,1 k €	-29.8%	350,4 k €	-22.1%	449,7 k €	-12.7%	514,9 k €	+41.0%	365,1 k €	-14.1%	424,9 k €	-15.6%	503,4 k €	+8.0%	465,9 k €	+23.5%	377,4 k €	+840%	40,2 k €	-39.8%	66,8 k €	+123%	30 k €
Other
Workforce	0,8 ETP	0.0%	0,8 ETP		0,0 ETP	-100%	0,8 ETP	-63.6%	2,2 ETP	-26.7%	3,0 ETP	+20.0%	2,5 ETP	+31.6%	1,9 ETP	+35.7%	1,4 ETP	+75.0%	0,8 ETP	-11.1%	0,9 ETP	-62.5%	2,4 ETP	0.0%	2,4 ETP	0.0%	2,4 ETP

Estimate

Indicative valuation

As an indication, this company is worth

between 1 M€ and 2,5 M€

See the valuation

Governance

Board of directors

Seen on filing of 31/12/2024 · 1 active · 7 ended

Active mandates

Pharmagrex

Director · 0635.846.678

Represented by Bleys MARTINE

Active

Ended mandates

Pharmagrex

Director · since 01 septembre 2015 · 0635.846.678

Represented by Martine Bleys

Ended

Pharmagrex

Manager · since 01 septembre 2015 · 0635.846.678

Represented by Martine Bleys

Ended

Pharmagrex NV

Bestuurder · since 01 septembre 2015

Represented by Martine Bleys

Ended

Filip Baute

Manager · since 20 novembre 2013

Ended

At this address

Other companies at this address

Company	CBE no.
Pharmagrex● Active	0635.846.678

Annual accounts

Full financial information

	2024	2023	2022	2021	2020	2019
Type of account	Abridged model	Abridged model	Abridged model	Abridged model	Abridged model	Abridged model
Start of the financial year	01/01/2024	01/01/2023	01/01/2022	01/01/2021	01/01/2020	01/01/2019
Closing of the financial year	31/12/2024	31/12/2023	31/12/2022	31/12/2021	31/12/2020	31/12/2019
Length of the financial year	12 months	12 months	12 months	12 months	12 months	12 months
Filing date	04/09/2025	17/12/2024	18/12/2023	29/09/2022	17/08/2021	29/07/2020
General meeting	30/06/2025	30/06/2024	30/06/2023	03/06/2022	04/06/2021	05/06/2020
Currency of the financial year	EUR	EUR	EUR	EUR	EUR	EUR
NBB quality label	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls

Ratios

Financial ratios

Looking for more information about this company?

Try for 7 days

Filings

Annual accounts filings

20 filings with the NBB

Model	Closing	General meeting	Filed	Language	Document
Abridged model	31/12/2024	30/06/2025	04/09/2025	Dutch	PDF
Abridged model	31/12/2023	30/06/2024	17/12/2024	Dutch	PDF
Abridged model	31/12/2022	30/06/2023	18/12/2023	Dutch	PDF
Abridged model	31/12/2021	03/06/2022	29/09/2022	Dutch	PDF
Abridged model	31/12/2020	04/06/2021	17/08/2021	Dutch	PDF
Abridged model	31/12/2019	05/06/2020	29/07/2020	Dutch	PDF
Abridged model	31/12/2018	07/06/2019	19/07/2019	Dutch	PDF
Abridged model	31/12/2017	01/06/2018	26/07/2018	Dutch	PDF
Abridged model	31/12/2016	02/06/2017	08/08/2017	Dutch	PDF
Abridged model	31/12/2015	03/06/2016	22/08/2016	Dutch	PDF
Abridged model	31/12/2014	05/06/2015	24/07/2015	Dutch	PDF
Abridged model	31/12/2013	06/06/2014	30/07/2014	Dutch	PDF
Abridged model	31/12/2012	07/06/2013	22/07/2013	Dutch	PDF
Abridged model	31/12/2011	01/06/2012	17/07/2012	Dutch	PDF
Abridged model	31/12/2010	03/06/2011	21/07/2011	Dutch	PDF
Abridged model	30/06/2010	24/09/2010	18/01/2011	Dutch	PDF
Abridged model	30/06/2009	25/09/2009	05/02/2010	Dutch	PDF
Abridged model	30/06/2008	26/09/2008	23/12/2008	Dutch	PDF
Abridged model	31/12/2007	30/05/2008	15/07/2008	Dutch	PDF
Abridged model	31/12/2006	25/05/2007	29/06/2007	Dutch	PDF

Estimate

Indicative valuation

Order of magnitude

As an indication, this company is worth

between 1 M€ and 2,5 M€

The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.

Discover the Business plan

Disclaimer

Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.

Governance

Board of directors

Seen on filing of 31/12/2024 · 1 active · 7 ended

Active mandates

Pharmagrex

Director · 0635.846.678

Represented by Bleys MARTINE

Active

Ended mandates

Pharmagrex

Director · since 01 septembre 2015 · 0635.846.678

Represented by Martine Bleys

Ended

Pharmagrex

Manager · since 01 septembre 2015 · 0635.846.678

Represented by Martine Bleys

Ended

Pharmagrex NV

Bestuurder · since 01 septembre 2015

Represented by Martine Bleys

Ended

Filip Baute

Manager · since 20 novembre 2013

Ended

Shareholders

Ownership and network

Looking for more information about this company?

Try for 7 days

Belgian Official Gazette

Belgian Official Gazette publications

Mandates13/10/2015
BENAMING - ONTSLAGEN - BENOEMINGEN - STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, )
PDF
Mandates03/12/2013
ONTSLAGEN - BENOEMINGEN
PDF
Mandates01/10/2010
ONTSLAGEN - BENOEMINGEN - BOEKJAAR
PDF
Mandates20/06/2008
ONTSLAGEN - BENOEMINGEN - BOEKJAAR
PDF
Capital / shares19/09/2007
KAPITAAL - AANDELEN - ALGEMENE VERGADERING - STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, )
PDF
Capital / shares16/10/2006
KAPITAAL - AANDELEN - STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, )
PDF

Source: Belgian Official Gazette

Competition

Similar companies

A company's peers, by sector and size, are included in the Business plan.

See the Business plan

2024
Annual accounts 2024290,2 k €↓
2023
Annual accounts 2023323 k €↑
2022
Annual accounts 2022222,4 k €↑
2022
Name changeAp. Pharmamax
2021
Annual accounts 2021188,3 k €↑
2021
Name changePharmamax BVBA
2014
Annual accounts 2014-27,9 k €↑
2013
Annual accounts 2013-156,5 k €↓
2012
Annual accounts 2012-56,2 k €↑
2011
Annual accounts 2011-64,3 k €↓
2010
Annual accounts 201030,5 k €↑
2010
Annual accounts 2010-5,4 k €↑
2009
Annual accounts 2009-7,9 k €↓
2008
Annual accounts 20086,7 k €↓
2007
Annual accounts 200715,9 k €↑
2006
Annual accounts 2006-22,2 k €
04/06/1988
IncorporationPrivate company with limited liability

10/15	1 240 000	1 180 000	1 050 000
70	8 630 000	8 120 000	7 940 000
9904	412 000	388 000	301 000
17/49	2 970 000	3 140 000	3 380 000
9087	24,3	23,1	21,8

Ap. Pharmamax

Overview

What does Ap. Pharmamax do?

Trend over 14 financial years

Indicative valuation

Board of directors

Other companies at this address

Financials

Full financial information

Financial ratios

Annual accounts filings

Valuation

Indicative valuation

Directors & structure

Board of directors

Ownership and network

Publications

Belgian Official Gazette publications

Similar companies

Similar companies

Timeline